Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 50,165 | 39,986 | 34,943 | 35,060 | 31,378 |
| Operating Income | -50,165 | -39,986 | -34,943 | -35,060 | -31,378 |
| Other Income | 2,614 | 3,036 | 2,368 | 1,230 | 718 |
| Pre-tax Income | -47,551 | -36,950 | -32,575 | -33,830 | -30,660 |
| Net Income Continuous | -47,551 | -36,950 | -32,575 | -33,830 | -30,660 |
| Net Income | $-47,551 | $-36,950 | $-32,575 | $-33,830 | $-30,660 |
| EPS Basic Total Ops | -0.38 | -0.30 | -0.26 | -0.36 | -0.34 |
| EPS Basic Continuous Ops | -0.38 | -0.30 | -0.26 | -0.36 | -0.34 |
| EPS Diluted Total Ops | -0.38 | -0.30 | -0.26 | -0.36 | -0.34 |
| EPS Diluted Continuous Ops | -0.38 | -0.30 | -0.26 | -0.36 | -0.34 |
| EBITDA(a) | $-51,074 | $-40,947 | $-35,635 | $-35,196 | $-31,154 |